KINETA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.481 USD | +6.42% |
|
-7.50% | -86.75% |
| 04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
| 03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
Chart calendar Kineta, Inc.
704d0a5dfb622ca63f175.FEM6CDhvw_ZQcKp247BTMxDe5Ln4WGhvocd0PHndbBY.UC94Wldf9owdSPIlp51qWUjusv-2azIFkagGCjzpJWd6Mk5taDy5ggAp4w~85849697f5633f1bb51a12d3a0993778
Upcoming events on Kineta, Inc.
Past events on Kineta, Inc.
| 2024-05-15 16:01 | Q1 2024 Earnings Release |
| 2024-03-21 16:02 | Q4 2023 Earnings Release |
| 2024-03-05 18:45 | American Association for Cancer Research Blood Cancer Discovery Symposium - VISTA a potential new Im |
| 2024-03-04 12:30 | Opal Group Family Office Winter Forum |
| 2024-02-26 | Immuno-Oncology 360 Conference |
| 2024-02-26 09:45 | BIO CEO & Investor Conference |
| 2024-02-13 11:00 | H C Wainwright Home Fireside Chat Series |
| 2023-12-14 11:30 | OTC Markets Group Life Science Investor Forum |
| 2023-12-05 14:00 | Investor Meeting - Key Opinion Leaders |
| 2023-11-14 09:30 | Macrophage Directed Therapies Summit |
| 2023-11-04 12:00 | Society for Immunotherapy of Cancer Meeting - Abstract No. - 780 |
| 2023-11-03 16:01 | Q3 2023 Earnings Release |
| 2023-11-03 12:00 | Society for Immunotherapy of Cancer Meeting - Abstract No. - 1357 |
| 2023-10-20 01:50 | OPAL Group Family Office And Private Wealth Management Forum |
| 2023-10-17 16:15 | BIO Investor Forum |
| 2023-10-08 | JonesTrading Healthcare Summit |
| 2023-10-03 16:45 | AACR Tumor Immunology and Immunotherapy Conference - Poster Number : B034 |
| 2023-10-03 07:15 | American Association for Cancer Research Special Conference |
| 2023-09-18 | Northland Capital Markets Institutional Investor Conference |
| 2023-09-13 11:00 | H.C. Wainwright Global Investment Conference |
Past dividends on Kineta, Inc.
| 2022-12-18 | 1.43 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 5,44 5,59 -2.68% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -15,7 -15,9 1.41% | -24,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -14,1 -15,8 11.19% | -24,0 |
|
Net income Million USD | Released Forecast Spread | -63,4 | -14,1 -15,8 10.74% | -24,0 |
|
EPS USD | Released Forecast Spread | -12,9 | -1,28 -1,40 8.24% | -1,41 |
| Announcement Date | 31/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,28 0,00 - | 5,16 0,23 2139.05% | 0,00 0,15 - | 0,00 0,15 - |
|
EBIT Million USD | Released Forecast Spread | -6,49 -6,20 -4.61% | -0,98 -5,83 83.19% | -3,99 -5,61 28.97% | -4,27 -4,50 5% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,31 -5,54 4.05% | -2,66 -4,42 39.81% | ||
|
Net income Million USD | Released Forecast Spread | -6,45 | 0,39 -4,96 107.78% | -5,38 -5,54 2.8% | -2,65 -4,42 39.94% |
|
EPS USD | Released Forecast Spread | 0,04 -0,52 107.69% | -0,46 -0,55 16.36% | -0,19 -0,29 34.48% | |
| Announcement Date | 11/05/23 | 11/08/23 | 03/11/23 | 21/03/24 |
More events
Past sector events for Kineta, Inc.
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KA Stock
- Calendar Kineta, Inc.
